$45.42
-0.76-1.65%
At Close: -
$45.42
00.00%
After Hours: Sep 20, 4:02 PM EDT
15 minutes delayed
Revolution Medicines reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Revolution Medicines using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.81 | $-0.77 | -5.19 % |
Mar 2024 | 2024-05-08 | $-0.70 | $-0.75 | 6.67 % |
Dec 2023 | 2024-02-26 | $-1.14 | $-0.90 | -26.7 % |
Sep 2023 | 2023-11-06 | $-0.99 | $-1.01 | 1.98 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $0 | $750.00K | -100.0 % |
Mar 2024 | 2024-05-08 | $0 | $1.44M | -100.0 % |
Dec 2023 | 2024-02-26 | $742.00K | $1.09M | -31.9 % |
Sep 2023 | 2023-11-06 | $0 | $750.00K | -100.0 % |
Revolution Medicines (RVMD) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.81, which missed the estimate of $-0.77.
The Actual Revenue was $0K, which missed the estimate of $750K.
Browse earnings estimates, EPS, and revenue on all stocks.